These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35552566)

  • 1. Hypoglycaemia due to insulin therapy for the management of hyperkalaemia in hospitalised adults: A scoping review.
    Chothia MY; Humphrey T; Schoonees A; Chikte UME; Davids MR
    PLoS One; 2022; 17(5):e0268395. PubMed ID: 35552566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reducing the harm associated in treating hyperkalaemia with insulin and dextrose.
    Abou Sherif S; Katsaiti I; Jebb H; Banh S; Bedi R; Levy J; Thomas D; Ashby D; Corbett R
    Clin Med (Lond); 2024 Jul; 24(4):100222. PubMed ID: 38871123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood glucose reduction in patients treated with insulin and dextrose for hyperkalaemia.
    Aljabri A; Perona S; Alshibani M; Khobrani M; Jarrell D; Patanwala AE
    Emerg Med J; 2020 Jan; 37(1):31-35. PubMed ID: 31653693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iatrogenic hypoglycaemia following glucose-insulin infusions for the treatment of hyperkalaemia.
    Tee SA; Devine K; Potts A; Javaid U; Razvi S; Quinton R; Roberts G; Leech NJ
    Clin Endocrinol (Oxf); 2021 Feb; 94(2):176-182. PubMed ID: 32979855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoglycaemia following treatment of hyperkalaemia with insulin and dextrose.
    Williams PS; Davenport A; Bone JM
    Postgrad Med J; 1988 Jan; 64(747):30-2. PubMed ID: 3047719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors, prevention and treatment of hypoglycaemia after hyperkalaemia in adult patients using intravenous insulin: An integrative review.
    Long DS; Kelly MA; Lim SH
    Int J Nurs Pract; 2023 Feb; 29(1):e13080. PubMed ID: 35859317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interventions for non-oliguric hyperkalaemia in preterm neonates.
    Vemgal P; Ohlsson A
    Cochrane Database Syst Rev; 2007 Jan; (1):CD005257. PubMed ID: 17253550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal Dose and Method of Administration of Intravenous Insulin in the Management of Emergency Hyperkalemia: A Systematic Review.
    Harel Z; Kamel KS
    PLoS One; 2016; 11(5):e0154963. PubMed ID: 27148740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interventions for non-oliguric hyperkalaemia in preterm neonates.
    Vemgal P; Ohlsson A
    Cochrane Database Syst Rev; 2012 May; 2012(5):CD005257. PubMed ID: 22592703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-acting insulin analogues versus regular human insulin for adults with type 1 diabetes mellitus.
    Fullerton B; Siebenhofer A; Jeitler K; Horvath K; Semlitsch T; Berghold A; Plank J; Pieber TR; Gerlach FM
    Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD012161. PubMed ID: 27362975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency of serum blood glucose monitoring after hyperkalaemia treatment using insulin and dextrose.
    Aljabri AM; Alsulami SA
    J Taibah Univ Med Sci; 2022 Feb; 17(1):82-86. PubMed ID: 35140569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcomes associated with the emergency treatment of hyperkalaemia with intravenous insulin-dextrose.
    Humphrey TJL; James G; Wilkinson IB; Hiemstra TF
    Eur J Intern Med; 2022 Jan; 95():87-92. PubMed ID: 34625340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of insulin doses for treatment of hyperkalaemia in intensive care unit patients with renal insufficiency.
    Verdier M; DeMott JM; Peksa GD
    Aust Crit Care; 2022 May; 35(3):258-263. PubMed ID: 34167889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between Optimum Mini-doses of Glucagon and Insulin Levels when Treating Mild Hypoglycaemia in Patients with Type 1 Diabetes - A Simulation Study.
    Ranjan A; Wendt SL; Schmidt S; Madsbad S; Holst JJ; Madsen H; Knudsen CB; Jørgensen JB; Nørgaard K
    Basic Clin Pharmacol Toxicol; 2018 Mar; 122(3):322-330. PubMed ID: 28922582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergency interventions for hyperkalaemia.
    Mahoney BA; Smith WA; Lo DS; Tsoi K; Tonelli M; Clase CM
    Cochrane Database Syst Rev; 2005 Apr; 2005(2):CD003235. PubMed ID: 15846652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of suspend-before-low insulin pump technology in hypoglycaemia-prone adults with type 1 diabetes (SMILE): an open-label randomised controlled trial.
    Bosi E; Choudhary P; de Valk HW; Lablanche S; Castañeda J; de Portu S; Da Silva J; Ré R; Vorrink-de Groot L; Shin J; Kaufman FR; Cohen O;
    Lancet Diabetes Endocrinol; 2019 Jun; 7(6):462-472. PubMed ID: 31047902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of hyperkalaemia by altering the transcellular gradient in patients with renal failure: effect of various therapeutic approaches.
    Ngugi NN; McLigeyo SO; Kayima JK
    East Afr Med J; 1997 Aug; 74(8):503-9. PubMed ID: 9487416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral dextrose gel for the treatment of hypoglycaemia in newborn infants.
    Weston PJ; Harris DL; Battin M; Brown J; Hegarty JE; Harding JE
    Cochrane Database Syst Rev; 2016 May; (5):CD011027. PubMed ID: 27142842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do high fasting glucose levels suggest nocturnal hypoglycaemia? The Somogyi effect-more fiction than fact?
    Choudhary P; Davies C; Emery CJ; Heller SR
    Diabet Med; 2013 Aug; 30(8):914-7. PubMed ID: 23672623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contemporary rates of severe hypoglycaemia in youth with type 1 diabetes: variability by insulin regimen.
    Katz ML; Volkening LK; Anderson BJ; Laffel LM
    Diabet Med; 2012 Jul; 29(7):926-32. PubMed ID: 22417321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.